Drug API Market - Forecasts from 2019 to 2024

The global drug API market is projected to grow at a CAGR of 5.40% to reach US$200.385 billion by 2024, from US$146.141 billion in 2018. APIs or Active Pharmaceutical Ingredients are the active drug components showing therapeutic effects. The rising R&D expenditure, growing pharmaceutical industry is driving the growth of the global drug API market in the forecast period. A substance used in a finished pharmaceutical product (FPP), intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human beings (source: WHO). Furthermore, the prevalence of chronic diseases worldwide and incidences of cancer are driving the market growth. The United States followed by Europe are expected to have a significant market share, while the Asia-Pacific region will witness high growth driven by the booming API manufacturing in China.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global drug API value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global drug API market.

Major industry players profiled as part of the report are Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma and Cipla Inc. among others.

Segmentation

The global drug API market has been analyzed through following segments:

By Drug Synthesis Type

Biotech Drugs
Synthetic Drugs

By Application

Generic Drugs
Branded Drugs

By Geography

North America
USA
Canada
Mexico
Others

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others